Abstract
Our study was designed to examine the effects of IL-2 gene therapy in a surgical minimal residual tumour disease (SMRTD). Mice were inoculated s.c. with methylcholanthrene (MC)-induced MC12 sarcoma cells. When the tumours reached 8 to 12 mm in diameter, they were excised, either completely ("microscopic SMRTD") or incompletely ("macroscopic SMRTD"). On day 90 after surgery, the tumour recurrence rate in untreated mice with microscopic SMRTD was approximately 30%, whereas in those with macroscopic SMRTD it was 75%. After surgery, experimental mice were treated with 2 types of irradiated, IL-2 gene-modified, IL-2-producing tumour cell vaccine. One type of vaccine was derived from the MC12 sarcoma cells (MC12-1L2/IV-3); the other type was derived from an unrelated X63-Ag8.653 plasmacytoma (X63-m-IL-2). Both types of vaccine failed to cure the macroscopic SMRTD. Whereas the X63-m-IL-2 vaccine was also ineffective in the microscopic SMRTD, the MC12-IL2/IV-3 vaccine was capable of preventing growth in all but one mouse (1164) with microscopic SMRTD when administered 2 to 5 days after surgery. If the vaccination took place 2 days before surgery or later than 5 days after surgery, the therapeutic activity was lost. Vaccination with irr...Continue Reading
References
Mar 15, 1978·International Journal of Cancer. Journal International Du Cancer·J BubeníkJ Anderlíková
Feb 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S A Rosenberg
May 1, 1991·The Journal of Urology·J D Fleischmann, B Kim
Jan 1, 1990·Methods in Cell Biology·P K HoranS E Slezak
Oct 1, 1990·The Journal of Experimental Medicine·B GansbacherE Gilboa
Feb 1, 1990·Immunology Letters·J BubeníkT Jandlová
Jan 1, 1988·European Journal of Immunology·H Karasuyama, F Melchers
Jan 1, 1985·Cancer Immunology, Immunotherapy : CII·J BubeníkA Toulcová
Nov 30, 1968·Nature·J Bubenik, A Turano
Jan 1, 1983·Cancer Immunology, Immunotherapy : CII·J BubeníkJ Neuwirt
Jan 1, 1995·Journal of Cancer Research and Clinical Oncology·J BubeníkM Indrová
Apr 7, 1993·Journal of the National Cancer Institute·S C TsaiG H Heppner
Jan 12, 1996·Science·R M Zinkernagel
Jul 1, 1996·Oncology·F BrivioL Fumagalli
Jan 1, 1997·Journal of the National Cancer Institute·J A Roth, R J Cristiano
Citations
Dec 7, 2017·Oncoimmunology·Romana MikyskovaMilan Reinis
Feb 26, 2000·Pediatric Hematology and Oncology·I Yaniv
Feb 21, 2008·Cancer·Justin StebbingHyam Levitsky
Sep 12, 2000·Gene Therapy·S B GeutskensR C Hoeben
Feb 26, 2000·Pediatric Hematology and Oncology·V VlkD Pospísilová